Summary

Asthma is a heterogeneous disease with respect to clinical features, cellular components of airway inflammation, and response to prescribed treatment. To better understand patients who remain symptomatic despite standard treatment with anti-inflammatory drugs and bronchodilators, investigators are exploring the molecular, genetic, and environmental determinants of asthma phenotypes in adults and children with asthma.